Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate® P/Humate-P®)In von Willebrand Disease and Haemophilia A

被引:0
|
作者
Natalie J. Carter
Lesley J. Scott
机构
[1] Wolters Kluwer Health ¦ Adis,
[2] Wolters Kluwer Health,undefined
来源
Drugs | 2007年 / 67卷
关键词
Factor VIII; Bleeding Episode; Coagulation Factor VIII; Viii Complex; Factor Viii Inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
▲ Haemate® P/Humate-P® is a pasteurised human plasma-derived concentrate containing coagulation factor VIII and a near-normal spectrum of von Willebrand factor multimers, including high-molecular weight multimers, for intravenous use in patients with von Willebrand disease or haemophilia A.▲ Extensive clinical experience over the past 25 years has shown that Haemate® P/Humate-P® provides effective haemostatic control for the prevention and treatment of bleeds in patients with these conditions, with no confirmed cases of viral or prion transmission occurring during this time.▲ In small prospective and retrospective noncomparative studies, Haemate® P/Humate-P® provided effective haemostatic control for the prevention and treatment of bleeding episodes in the vast majority of paediatric and adult patients with von Willebrand disease.▲ Haemate® P/Humate-P® was generally well tolerated in patients with von Willebrand disease or haemophilia A.
引用
收藏
页码:1513 / 1519
页数:6
相关论文
共 50 条
  • [1] Human plasma von Willebrand factor/factor VIII complex (Haemate® P/Humate-P®) -: In von Willebrand disease and haemophilia A
    Carter, Natalie J.
    Scott, Lesley J.
    [J]. DRUGS, 2007, 67 (10) : 1513 - 1519
  • [2] Human plasma von Willebrand factor/factor VIII complex (Haemate® P/Humate-P®) in von Willebrand disease and haemophilia A -: A viewpoint
    Berntorp, Eric
    [J]. DRUGS, 2007, 67 (10) : 1520 - 1520
  • [3] Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate® P/Humate-P®) in von Willebrand Disease and Haemophilia AA Viewpoint by Eric Berntorp
    Eric Berntorp
    [J]. Drugs, 2007, 67 : 1520 - 1520
  • [4] Efficacy and safety of the Factor VIII/von Willebrand factor concentrate, Haemate-P/Humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease
    Lillicrap, D
    Poon, MC
    Walker, I
    Xie, F
    Schwartz, BA
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 87 (02) : 224 - 230
  • [5] von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease
    Gill, J. C.
    Shapiro, A.
    Valentino, L. A.
    Bernstein, J.
    Friedman, C.
    Nichols, W. L.
    Manco-Johnson, M.
    [J]. HAEMOPHILIA, 2011, 17 (06) : 895 - 905
  • [6] Von Willebrand factor/factor VIII concentrate (Humate-P®) for surgical prophylaxis of excessive bleeding in patients with von Willebrand disease (VWD).
    Gill, JC
    DiPaola, J
    Bernstein, J
    Leissinger, CA
    Valentino, L
    Friedman, C
    Knaub, S
    [J]. BLOOD, 2005, 106 (11) : 509A - 509A
  • [7] Pharmacokinetics and dose linearity of von Willebrand factor factor VIII concentrate (Humate-P®) in elective surgery in von Willebrand disease patients.
    DiPaola, J
    Gill, J
    Bernstein, J
    Leissinger, C
    Valentino, L
    Friedman, C
    Knaub, S
    [J]. BLOOD, 2005, 106 (11) : 509A - 510A
  • [8] Haemate® P/Humate-P® for the treatment of von Willebrand disease: considerations for use and clinical experience
    Auerswald, G.
    Kreuz, W.
    [J]. HAEMOPHILIA, 2008, 14 : 39 - 46
  • [9] Efficacy and safety of factor VIII/von Willebrand factor concentrate Haemate P in von Willebrand patients undergoing surgery
    Zotz, R.
    Mandaliev, A.
    Moeller, N.
    Scharf, R.
    [J]. HAEMOPHILIA, 2008, 14 : 118 - 118
  • [10] Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A
    Stokol, T
    Trepanier, L
    Parry, BW
    Finnin, BC
    [J]. RESEARCH IN VETERINARY SCIENCE, 1997, 63 (01) : 23 - 27